ACG: Combined Oral Contraceptives Increase Risk for Irritable Bowel Syndrome
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 24, 2023 -- Combined oral contraceptives (COCs) are associated with higher risks for developing irritable bowel syndrome (IBS) and its subtypes, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 20 to 25 in Vancouver, British Columbia, Canada.
Yuhan Fu, D.O., from the University of Louisville in Kentucky, and Gengqing Song, M.D., from Case Western Reserve University in Cleveland, assessed whether or not COCs are associated with higher risks for developing IBS. The analysis included 54,645 female patients (aged 15 to 45 years) who were prescribed COCs before 2018 and 54,645 propensity-matched control patients who underwent copper intrauterine device insertion before 2018.
The researchers found that over five years, patients who were prescribed COCs had higher risks for developing new-onset IBS (odds ratio [OR], 1.34 to 1.71) and its subtypes, including IBS with predominant constipation (OR, 1.82 to 4.14), IBS with predominant diarrhea (OR, 1.28 to 2.29), and IBS with mixed bowel habits (OR, 1.91 to 5.00).
"COCs are associated with higher risks of developing IBS and its subtypes," the authors write. "Further research would be necessitated to elucidate the role of estrogen and progesterone on the development and progression of IBS."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Decrease in Oral Contraceptive Fills Seen After Dobbs Ruling
WEDNESDAY, June 26, 2024 -- The Dobbs v Jackson Women's Health Organization decision, allowing states to strengthen restrictions on abortion access, was associated with declines...
ENDO: Novel Male Contraceptive Gel May Achieve Faster Sperm Suppression
WEDNESDAY, June 12, 2024 -- A novel male contraceptive gel suppresses sperm production faster than other hormone-based methods for male birth control, according to a phase 2 study...
Rates of Severe Multiple Drug Intolerance Syndrome Up in Fibromyalgia, IBS
THURSDAY, May 23, 2024 -- Patients with fibromyalgia and irritable bowel syndrome (IBS) have increased rates of severe multiple drug intolerance syndrome (MDIS), according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.